Dergiler / Türkderm Türk deri hastalıkları ve frengi arşivi / 2021 / Cilt: 55 - Sayı: 3

Coexistence of Touraine-Solente-Gole syndrome and type 1 neurofibromatosis: A case report

Nörofibromatozis tip 1 ve Touraine-Solente-Gole sendromu birlikteliği: Olgu Sunumu

Sayfa
143–146
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The coexistence of skin findings of two different diseases in the same patient indicates that both diseases may be related to different genetic pathways.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Pachydermoperiostosis is a rare syndrome that affects the skin and skeletal system.
📊
Temel Bulgular & Veri:A 57-year-old male patient was admitted to our clinic with growth complaints of growth his hands, feet, and face.
💡
Sonuç & Katkı:The coexistence of skin findings of two different diseases in the same patient indicates that both diseases may be related to different genetic pathways.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Pachydermoperiostosis is a rare syndrome that affects the skin and skeletal system. Mutations in the gene encoding hydroxyprostaglandin dehydrogenase (HPGD) are thought to play a role in disease etiopathogenesis. The disease is typically seen in males and is characterized by skin thickening (pachydermia), clubbing, and subperiosteal new bone formation. A 57-year-old male patient was admitted to our clinic with growth complaints of growth his hands, feet, and face. He had a prominence of forehead lines and fist-sized round bulges on his torso and face. The patient’s history also indicated that he was clinically followed up for neurofibromatosis 1 (NF1). No mutations in the HPGD and SLCO2A1 genes were identified. This is the first case in the literature that reviews pachydermoperiostosis and NF together. The coexistence of skin findings of two different diseases in the same patient indicates that both diseases may be related to different genetic pathways.

Abstract

Pakidermoperiostoz iskelet sistemi ve deriyi etkileyebilen genetik geçişli nadir görülen bir hastalıktır. Hastalığın etiyopatogenezinde, hidroksiprostaglandin dehidrogenazı (HPGD) kodlayan gende mutasyonların rolü olduğu düşünülmektedir. Hastalık daha çok erkeklerde görülmekte ve deride kalınlaşma (pachydermia), çomak parmak, subperiostal yeni kemik oluşumu gibi klinik bulgularla seyretmektedir. Elli yedi yaşında erkek hasta el, ayaklarda ve yüzde büyüme, alın çizgilerinde belirginleşme, gövde ve yüzde ele gelen yuvarlak kabarıklıklar şikayeti ile kliniğimize başvurdu. Aynı zamanda hastanın nörofibromatöz 1 (NF1) nedeniyle tanı aldığı ve takipte olduğu öğrenildi. Yapılan analizde, HPGD ve SLCO2A1 genlerinde mutasyon görülmedi. Bu olgu NF ve pakidermoperiostoz birlikteliğinin görüldüğü nadir bir olgudur. Bu iki farklı hastalığın aynı hastada bir arada bulunması, bir genetik mutasyonun veya diğer altta yatan faktörlerin her iki durumun varlığından sorumlu olabileceğini düşündürmektedir.

🔖

Bu Makaleye Atıf Yap

KORKMAZ, H., ERTURAN, İ., AYVAZ, H. H., ÖZTÜRK, K. H., KORKMAZ, S. (2021). Coexistence of Touraine-Solente-Gole syndrome and type 1 neurofibromatosis: A case report. Türkderm Türk deri hastalıkları ve frengi arşivi, Cilt: 55 - Sayı: 3, 143–146. https://ajindex.com/articles/402207

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (17)

  1. Hong C, Devic N, Zavareh A, Desai A, Ng N: Pachydermoperiostosis: The Elephant Skin Disease. J Rheumatol. 2017;44:1680-1
  2. Kwon MY, Joung C: Pachydermoperiostosis Mimicking Acromegaly: A Case Report. Turk J Rheumatol 2012;27:132-5
  3. Zhang Q, Shen M, Yang B, Yu K: A complicated case of pachydermoperiostosis with spondyloarthritides: a case report. J Med Case Rep 2013;7:268
  4. Nakahigashi K, Otsuka A, Doi H, et al: Prostaglandin E2 increase in pachydermoperiostosis without 15-hydroprostaglandin dehydrogenase mutations. Acta Derm Venereol. 2013;93:118-9
  5. Mobini M, Akha O, Fakheri H, Majidi H, Fattahi S: Pachydermoperiostosis in a patient with Crohn’s disease: Treatment and literature review. Iran J Med Sci 2018;43:81-5
  6. Doshi D: Touraine-Solente-Gole syndrome. Orbit 2018;37:97-101
  7. Uchiyama Y, Sumi T, Marutani K, et al: Neurofibromatosis type 1 in the mandible. Ann Maxillofac Surg 2018;8:121-3
  8. Ferner RE, Gutmann DH: Neurofibromatosis type 1 (NF1): diagnosis and management. Handb Clin Neurol 2013;115:939-55
  9. Abdullah NRA, Jason WLC, Nasruddin AB: Pachydermoperiostosis: a rare mimicker of acromegaly. Endocrinol Diabetes Metab Case Rep 2017. Doi:10.1530/EDM-17-0029
  10. Shakya P, Pokhrel KN, Mlunde LB, Tan S, Ota E, Niizeki H: Effectiveness of nonsteroidal anti-inflammatory drugs among patients with primary hypertrophic osteoarthropathy: A systematic review. J Dermatol Sci 2018;90:21-6
  11. Gupta M, Lehl SS, Singh R, Sachdev A. Touraine-Solente-Gole’ syndrome. BMJ Case Rep 2011;28:1-4
  12. Durusoy Ç, Dilek A, Lakadamyalı H, Akaya H, Seçkin D. Primary complete pachydermoperiostosis: A sporodic case. T Klin J Med Sci 2003;23:245-9
  13. Lowenthal MN, Tombak A, Lowenthal A: Secondary hypertrophic osteoarthropathy (HOA) mimicking primary HOA (pachydermoperiostitis or Touraine-Solente-Golé) syndrome. Isr Med Assoc J 2004;6:64
  14. Supradeeptha C, Shandilya SM, Vikram Reddy K, Satyaprasad J. Pachydermoperiostosis-a case report of complete form and literatüre review. J Clin Orthop Trauma 2014;5:27-32
  15. Hozumi K, Fukuoka H, Odake Y, et al: Acromegaly caused by a somatotroph adenoma in patient with neurofibromatosis type 1. Endocr J 2019;66:853-7
  16. Inglıs K. Local gigantism (a manifestation of neurofibromatosis): its relation to general gigantism and to acromegaly; illustrating the influence of intrinsic factors in disease when development of the body is abnormal. Am J Pathol 1950;26:1059-83
  17. Athappan G, Unnikrishnan A, Chengat V, et al: